Takeda launches ORZEYFUL, first-in-class orexin receptor 2 agonist for narcolepsy type 1, in Japan and China
https://finviz.com/stock?t=TAK&p=d
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.